title: Biomarkers in psychosis: an approach to early identification and individualized treatment.
abstract: Numerous biomarkers for somatic disorders are used in routine medical practice. Yet, despite remarkable advances in mental health research, we are not able to identify biomarkers with established clinical utility for mental disorders such as schizophrenia. While identification and characterization of biomarkers are crucial first steps in this process, their predictive diagnostic and treatment utility need to be better developed for clinical practice. The heterogeneity of psychotic disorders etiologically, pathologically and symptomatically presents both a challenge and an opportunity for the use of biomarkers in clinical practice. Simply said, a single biomarker might not exist that necessitates the search for a biomarker profile. In this review we discuss research findings in light of such an approach. We summarize some examples of emerging biomarkers in early psychosis research and delineate how these can be applied to a clinical setting to inform treatment on an individual basis fostering a personalized treatment approach.
authors: Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0810, USA.
authors: Heline
authors: H
authors: Mirzakhanian
authors: Fiza
authors: F
authors: Singh
authors: Kristin S
authors: KS
authors: Cadenhead
mesh_terms: D000465:Algorithms; D015415:Biomarkers / Q000378:metabolism*; D042241:Early Diagnosis; D006801:Humans; D057285:Precision Medicine; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000628:therapy; D012559:Schizophrenia / Q000175:diagnosis / Q000628:therapy
chemical_list: D015415:Biomarkers